Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0441-2026

SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706 Recall

SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706

FDA recall Class II

Ongoing

FDA lists this Class II recall for SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0441-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Sep 17, 2025
FDA report date
Nov 12, 2025
Quantity in commerce
2,932 units
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706

Affected model & UDI checker

Search the exact identifiers published for Z-0441-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
969706SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706Check source noticeNot specified
FDA code information

REF: 969706. Lot: M404166. Expiration Date: 30Nov2025

View the original FDA recall notice

Why was this product recalled?

Beckman Coulter has identified that there is an increased probability Synchron Systems Direct LDL Cholesterol (LDLD REF 969706) reagent lot M404166 may generate false high results. The issue was discovered internally and confirmed on August 19, 2025 by Beckman Coulter.

What actions did BECKMAN COULTER, INC. take?

Beckman Coulter notified consignees via letter on about 09/17/2025. Consignees were instructed to discontinue use of SYNCHRON Systems LDLD reagent lot M404166 and contact Customer Technical Support Center for assistance, review the Safety Data Sheet (SDS) and discard according to laboratory s Standard Operating Procedures and/or your local regulations. The SDS is available at www.beckmancoulter.com. Additionally, Beckman Coulter recommends sharing the content of this letter with laboratory and/or medical director regarding the need to perform a retrospective review of the patient results generated from the SYNCHRON Systems LDLD reagent lot M404166 to determine if retesting is necessary.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology